Document is current
Any future updates will be listed below
-
Authors
Ward, Leanne Marie
Chambers, Alexandra http://orcid.org/0000-0003-1250-2369
Mechichi, Emine
Wong-Rieger, Durhane
Campbell, Craig
-
Funding
Funding for this research was provided by:
novartis pharmaceuticals canada
- License Information
-
More Information
Article History
Received: 19 July 2021
Accepted: 20 February 2022
First Online: 4 March 2022
Declarations
:
: Not applicable.
: Not applicable.
: LMW has participated in clinical trials with, and/or been a consultant to, PTC, ReveraGen, Catabasis, Amgen, Novartis, Alexion, Ascendis, Ipsen, and Ultragenyx, with funds to LMW’s institution. AC and EM are employed by Novartis Pharmaceuticals.
